© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
December 05, 2020
Investigators evaluated patients from 3 Chicago hospital systems and assessed risk factors associated with thrombosis.
November 25, 2020
Liquidia Technologies plans on addressing FDA concerns regarding treprostinil.
October 23, 2020
Compared with prophylaxis anticoagulation, full dose anticoagulation provided a greater survival benefit to those in a predominantly black population.
October 02, 2020
The risk of VTE is increased in both hospitalized and non-hospitalized COVID-19 patients.
September 25, 2020
For obese patients, both weight gain and loss was linked to an increase in the rate of incident venous thromboembolism.
September 21, 2020
Treatments for VTE in children fall short as they require frequent monitoring and include unpredictable food and drug interactions.
September 17, 2020
Post-discharge thromboprophylaxis is not necessary.
The rate of adverse events was higher in patients suffering from both deep vein thrombosis and pulmonary embolisms than it was in just patients with DVT.
August 27, 2020
Future studies are needed to develop and validate better risk assessment tools.
August 12, 2020
Guideline adoption could lead to more use of thrombolytic therapy.